The Engines of Hippocrates
Encouraging the understanding of humans and disease down to the molecular level, The Engines of Hippocrates presents the hands-on perspective of authors Robson and Baek as they explain the history and techniques of, and assess the potential for, information-based medicine to improve the costs, efficiency, and practice of pharmaceutical and medical science. Covering a broad range of topics, the book presents scientists pursuing drug research and development as well as principal investigators, principal scientists, and research directors with timely topics that are impacting the pharmaceutical and biomedical industries.
512 Seiten
Hardcover
Erscheinungsdatum 10.07.2009
ISBN 9780470289532
BARRY ROBSON is Director of Medical Research and Professor of Biostatistics, Epidemiology, and Evidence Based Medicine at St. Matthew's University School of Medicine, and CEO of The Dirac Foundation, formed with the permission of Nobel laureate Paul A. M. Dirac's widow to promote understanding of the value of theoretical physics in human and veterinary medicine. Until recently, he was Chief Scientific Officer of IBM Global Healthcare and Life Sciences, and then Global Pharmaceutical and Life Sciences, an IBM Distinguished Engineer, and previously, Strategic Advisor at IBM Research headquarters. O. K. BAEK is a Senior Solutions Architect at IBM, specializing in healthcare and with a passionate interest in the benefits and long-standing logic of Oriental medicine. He is particularly interested in the development of novel architectures for sharing and using medical information securely, and in translational research, the matter of rapidly delivering the results of medical research and genomics to enhance everyday clinical decisions.
Encouraging the understanding of humans and disease down to the molecular level, The Engines of Hippocrates presents the hands-on perspective of authors Robson and Baek as they explain the history and techniques of, and assess the potential for, information-based medicine to improve the costs, efficiency, and practice of pharmaceutical and medical science. Covering a broad range of topics, the book presents scientists pursuing drug research and development as well as principal investigators, principal scientists, and research directors with timely topics that are impacting the pharmaceutical and biomedical industries.